Institution
Hospital Italiano de Buenos Aires
Healthcare•Buenos Aires, Argentina•
About: Hospital Italiano de Buenos Aires is a healthcare organization based out in Buenos Aires, Argentina. It is known for research contribution in the topics: Population & Medicine. The organization has 3193 authors who have published 3575 publications receiving 65683 citations.
Papers published on a yearly basis
Papers
More filters
TL;DR: This 5-year evaluation provides strong evidence that the classification of complications is valid and applicable worldwide in many fields of surgery, and subjective, inaccurate, or confusing terms such as “minor or major” should be removed from the surgical literature.
Abstract: Background and Aims:The lack of consensus on how to define and grade adverse postoperative events has greatly hampered the evaluation of surgical procedures. A new classification of complications, initiated in 1992, was updated 5 years ago. It is based on the type of therapy needed to correct the co
7,537 citations
TL;DR: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates, and there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries.
5,802 citations
Christopher J L Murray1, Christopher J L Murray2, Christopher J L Murray3, Aleksandr Y. Aravkin2 +2269 more•Institutions (286)
TL;DR: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure.
3,059 citations
Memorial Sloan Kettering Cancer Center1, Complutense University of Madrid2, Samsung Medical Center3, Hospital Italiano de Buenos Aires4, Aix-Marseille University5, University Hospital of Lausanne6, National and Kapodistrian University of Athens7, Bristol-Myers Squibb8, Emory University9, Princess Alexandra Hospital10, AstraZeneca11
TL;DR: First-line treatment with nivolumab plus ipilimumab resulted in a longer duration of overall survival than did chemotherapy in patients with NSCLC, independent of the PD-L1 expression level.
Abstract: Background In an early-phase study involving patients with advanced non–small-cell lung cancer (NSCLC), the response rate was better with nivolumab plus ipilimumab than with nivolumab mono...
1,588 citations
TL;DR: The number of adults with raised blood pressure increased from 594 million in 1975 to 1·13 billion in 2015, with the increase largely in low-income and middle-income countries, and the contributions of changes in prevalence versus population growth and ageing to the increase.
1,573 citations
Authors
Showing all 3224 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Robert F. LaPrade | 82 | 662 | 25013 |
| Catherine Y. Spong | 77 | 337 | 28992 |
| Jean-Marc Dumonceau | 67 | 204 | 15534 |
| Alexandre Abizaid | 56 | 498 | 12650 |
| Osvaldo A. Rosso | 49 | 241 | 8770 |
| Martin O'Flaherty | 48 | 245 | 15089 |
| Abrar A. Qureshi | 47 | 155 | 7732 |
| Mauricio G. Cohen | 43 | 257 | 7026 |
| Edward L. Trimble | 43 | 149 | 10418 |
| Eduardo de Santibañes | 42 | 170 | 12405 |
| Federico Milano | 40 | 287 | 7151 |
| Manuel Montero-Odasso | 40 | 162 | 7079 |
| Alejandro Gonzalez Della Valle | 40 | 160 | 4658 |
| Wolf-Henning Boehncke | 38 | 157 | 6020 |
| Jorge Chahla | 36 | 398 | 5408 |